DK392580A - Fremgangsmaade til fremstilling af 15-sulfonamidoprostaglandinderivater - Google Patents

Fremgangsmaade til fremstilling af 15-sulfonamidoprostaglandinderivater

Info

Publication number
DK392580A
DK392580A DK392580A DK392580A DK392580A DK 392580 A DK392580 A DK 392580A DK 392580 A DK392580 A DK 392580A DK 392580 A DK392580 A DK 392580A DK 392580 A DK392580 A DK 392580A
Authority
DK
Denmark
Prior art keywords
sulphonamidoprostagland
ingrediates
procedure
preparation
sulphonamidoprostagland ingrediates
Prior art date
Application number
DK392580A
Other languages
Danish (da)
English (en)
Inventor
T K Schaaf
J F Eggler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK392580A publication Critical patent/DK392580A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK392580A 1979-09-17 1980-09-16 Fremgangsmaade til fremstilling af 15-sulfonamidoprostaglandinderivater DK392580A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/076,520 US4232173A (en) 1979-09-17 1979-09-17 15-Sulfonamidoprostaglandin derivatives

Publications (1)

Publication Number Publication Date
DK392580A true DK392580A (da) 1981-03-18

Family

ID=22132532

Family Applications (1)

Application Number Title Priority Date Filing Date
DK392580A DK392580A (da) 1979-09-17 1980-09-16 Fremgangsmaade til fremstilling af 15-sulfonamidoprostaglandinderivater

Country Status (18)

Country Link
US (1) US4232173A (de)
EP (1) EP0025687B1 (de)
JP (1) JPS5951938B2 (de)
KR (1) KR840000964B1 (de)
AR (1) AR225776A1 (de)
AT (1) ATE1858T1 (de)
AU (1) AU518068B2 (de)
CA (1) CA1153368A (de)
DE (1) DE3061160D1 (de)
DK (1) DK392580A (de)
ES (1) ES8106489A1 (de)
FI (1) FI68615C (de)
GR (1) GR70288B (de)
IE (1) IE50266B1 (de)
IL (1) IL61038A (de)
PH (1) PH15098A (de)
PT (1) PT71807B (de)
YU (1) YU236180A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61126069A (ja) * 1984-11-21 1986-06-13 Res Dev Corp Of Japan プロスタグランジン誘導体
JPS63207015A (ja) * 1987-02-23 1988-08-26 株式会社日立製作所 遮断器装置
US5387608A (en) * 1993-08-17 1995-02-07 Allergan, Inc. Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
US5607415A (en) * 1994-08-18 1997-03-04 Kimberly-Clark Corporation Flexible absorbent article

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3835179A (en) * 1972-07-24 1974-09-10 American Cyanamid Co Novel 15-substituted prostanoic acids and esters
US4033996A (en) * 1973-04-25 1977-07-05 Merck & Co., Inc. 8-Aza-9-oxo(and dioxo)-thia-11,12-secoprostaglandins
GB1507211A (en) * 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues

Also Published As

Publication number Publication date
PH15098A (en) 1982-08-10
JPS5651448A (en) 1981-05-09
KR830003415A (ko) 1983-06-20
GR70288B (de) 1982-09-03
KR840000964B1 (ko) 1984-07-02
DE3061160D1 (en) 1982-12-30
FI68615C (fi) 1985-10-10
FI68615B (fi) 1985-06-28
ES495101A0 (es) 1981-08-16
IL61038A0 (en) 1980-11-30
YU236180A (en) 1983-01-21
CA1153368A (en) 1983-09-06
US4232173A (en) 1980-11-04
EP0025687A1 (de) 1981-03-25
IL61038A (en) 1983-12-30
PT71807A (en) 1980-10-01
EP0025687B1 (de) 1982-11-24
PT71807B (en) 1981-07-02
AR225776A1 (es) 1982-04-30
ES8106489A1 (es) 1981-08-16
IE50266B1 (en) 1986-03-19
FI802904A7 (fi) 1981-03-18
JPS5951938B2 (ja) 1984-12-17
AU6243680A (en) 1981-03-26
IE801927L (en) 1981-03-17
AU518068B2 (en) 1981-09-10
ATE1858T1 (de) 1982-12-15

Similar Documents

Publication Publication Date Title
DK29681A (da) Fremgangsmaade til fremstilling af immunogammaglobulin
DK546080A (da) Fremgangsmaade til fremstilling af galactosaccharosederivater
DK311580A (da) Fremgangsmaade til fremstilling af oxoalkylxanthiner
DK6180A (da) Fremgangsmaade til fremstilling af 2-pennemforbindelser
DK365280A (da) Fremgangsmaade til fremstilling af ftaliminderivater
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK552180A (da) Fremgangsmaade til fremstilling af tetrapeptidsemikarbazidderivater
DK274580A (da) Fremgangsmaade til fremstilling af tripeptidamider
DK149623C (da) Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider
DK394080A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK153791C (da) Fremgangsmaade til fremstilling af 7-hydroxycumaraner
DK481280A (da) Fremgangsmaade til fremstilling af piperidylbenzimidazolinonderivater
DK262180A (da) Fremgangsmaade til fremstilling af alkyl-2-chlorpropionater
DK187980A (da) Fremgangsmaade til fremstilling af benzimidazolderivater
DK274680A (da) Fremgangsmaade til fremstilling af tripeptidamider
DK222880A (da) Fremgangsmaade til fremstilling af anthracyclinonderivater
DK304080A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK69680A (da) Fremgangsmaade til fremstilling af diorganomagnesiumforbindelser
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK318280A (da) Fremgangsmaade til fremstilling af naphthyridinderivater
DK546180A (da) Fremgangsmaade til fremstilling af triazepinderivater
DK199981A (da) Fremgangsmaade til fremstilling af thiobiscarbamater
DK156427C (da) Fremgangsmaade til fremstilling af n-alkylarylaminer
DK32580A (da) Fremgangsmaade til fremstilling af alkylarylethere

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment